Across TCGA pan-cancer cohorts, CT45A3 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated CT45A3 data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher CT45A3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CT45A3 expression acts as an unfavorable survival marker, although some lineages such as OV and LUAD show a favorable association.
COAD, KIRC, and STAD are the cancer types where CT45A3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.